Survey
Results
SummaryExpertsCelebritiesConsumers 
Consumers survey results of 2013 in category
Digestive system and hepatology / The medication from diahrea
Info The annual ratings by results of Consumers survey calculated as average arithmetic mean rank, obtained in each of 4 quarters of year.
 
 I quarter (january—march)
 
 II quarter (april—june)
 
 III quarter (july—september)
 
 IV quarter (october—december)
1. Atoxil (Orisil-Pharm) Favorite of Consumers – 2013 Link 39.68% 5
    
2. Enterosgelum (Kreoma-Pharm)Link 33.33% 4.21
    
3.
4
 Смекта (Beaufour Ipsen Pharma)Link 28.57% 4.03
    
4.
5
 Sorbex (Валартін Фарма)Link 22.22% 3.12
    
5.
7
 Лоперамід-Здоров’я (Pharmaceutical company “Zdorovya”)Link 12.70% 2.04
    
6. Hylak forte (ratiopharm) 11.11% 1.88
    
7.
9
 Регідрон (Orion Pharma)Link 14.29% 1.85
    
8.
3
 Imodium (Johnson & Johnson) 9.52% 1.27
    
9.
10
 Phosphalugel (Astellas Europe) 9.52% 1.13
   
10.
11
 Ентерол (Біокодекс Україна)Link 6.35% 1.11
   
11.
~
 Лоперамід-ЛХ (Лекхім)Link 6.35% 0.85
   
12.
~
 Лактусан (ТОВ “Феліцата Україна”)Link 6.35% 0.83
  
–.
~
 Біфі-форм (Ferrosan)Link 1.59% 0.71
 
13. Лопедіум (Sandoz)Link 4.76% 0.50
  
14.
12
 Lacidofil (PharmUnion)Link 3.17% 0.40
  
15.
13
 Діаремікс (Mili Healthcare)Link 1.59% 0.36
 
16.
13
 Стоперан (EU Pharmacia) 1.59% 0.24
 
View results of current, 2024 year  Show all preparations

Normed consumer's score are calculated by 5-score scale, accordingly to the methodic of the research.
Notice
The competitor which has taken 1st place in this rating — is the best and the most successful Ukrainian medication of 2013 in the “The drug from diahrea” category!
Using this rating is only possible with obligatory link to the source.
This rating was built as a result of the study of social preferences in 2013, under the “Favorites of Success” Contest in Ukraine and it’s the free information. In case of full or partial republishing of the information drawn from this rating, it is obligatory to mention the name of the “Favorites of Success” Contest in printed publications, or put an active hyperlink to this page in the electronic media.  Details…
Comments(38)
all in a row | positive | negative

No negative comments yet… Be the first to leave comment on this topic!

or
You may sign in using:
Enter with Facebook Enter with Google Enter with VK
Aye Nay
  

Achtung! Please be polite! Although that modertors of this web-portal are excessively democratic, any unethical, unqotable or just rude expressions, which abuse other visitors of this web site, can be deleted. Also will be deleted any spam and public comments with private phone numbers.